AIV Logo AIV Assistant

 Logo Alliance Pharma plc - APH.L 64.70 GBX

EPS
-0.06
P/B
101.46
ROE
-13.44
Beta
0.67
Target Price
61.00 GBX

64.700 GBX

64.700 GBX

Daily: +0.00%
Key Metrics

EPS: -0.06

Book Value: 0.41

Price to Book: 101.46

Debt/Equity: 47.46

% Insiders: 11.948%

Growth

Revenue Growth: 0.03%

Earnings Growth: -0.09%

Estimates

Forward P/E: 8.24

Forward EPS: 5.07

Target Mean Price: 61.00

 Logo About Alliance Pharma plc - (APH.L)

Country: United Kingdom

Sector: Health Care

Website: http://www.alliancepharmaceuticals.com

Alliance Pharma plc acquires, markets, and distributes consumer healthcare products and prescription medicines in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. It provides its products under the Aloclair, Anbesol, Asthon & Parsons, Forceval, Hydromol, Kelo-Cote, MacuShield, Vamousse, Nizoral, and Amberen brand names. The company was incorporated in 1996 and is headquartered in Chippenham, the United Kingdom.

Exchange Ticker
LSE (United Kingdom) APH.L
ASX (Australia) APH.AX
FRA (Germany) DVL.F
Historical Dividends
Year Total Dividends
2023 1.78 GBX
2022 1.69 GBX
2021 1.61 GBX
2020 0.54 GBX
2019 1.46 GBX
2018 1.33 GBX
2017 1.21 GBX
2016 1.10 GBX
2015 1.00 GBX
2014 0.91 GBX
2013 0.83 GBX
2012 0.75 GBX
2011 0.40 GBX
2010 0.30 GBX

Yearly aggregated dividends

Dividends

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion